BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19210694)

  • 1. Mortality is influenced by locality in a major HIV/AIDS epidemic.
    Druyts EF; Rachlis BS; Lima VD; Harvard SS; Zhang W; Brandson EK; Strathdee SA; Montaner JS; Hogg RS
    HIV Med; 2009 May; 10(5):274-81. PubMed ID: 19210694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
    Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
    Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
    Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
    Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
    García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
    J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Larsen CS; Jensen J; Obel N; Kronborg G
    Addiction; 2010 Mar; 105(3):529-35. PubMed ID: 20402997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
    Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
    Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia.
    Lloyd-Smith E; Brodkin E; Wood E; Kerr T; Tyndall MW; Montaner JS; Hogg RS
    AIDS; 2006 Feb; 20(3):445-50. PubMed ID: 16439879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
    Lima VD; Hogg RS; Harrigan PR; Moore D; Yip B; Wood E; Montaner JS
    AIDS; 2007 Mar; 21(6):685-92. PubMed ID: 17413689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
    Hogg RS; Yip B; Kully C; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
    CMAJ; 1999 Mar; 160(5):659-65. PubMed ID: 10102000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
    Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.
    Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
    HIV Med; 2007 Mar; 8(2):80-5. PubMed ID: 17352763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rising HIV infection rates in Ho Chi Minh City herald emerging AIDS epidemic in Vietnam.
    Lindan CP; Lieu TX; Giang LT; Lap VD; Thuc NV; Thinh T; Lurie P; Mandel JS
    AIDS; 1997 Sep; 11 Suppl 1():S5-13. PubMed ID: 9376101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
    Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
    Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home is where the HAART is: an examination of factors affecting neighbourhood perceptions among people with HIV/AIDS on antiretroviral therapy.
    Vasarhelyi K; Brandson EK; Palmer AK; Fernandes KA; Zhang W; Moore DM; Montaner JS; Hogg RS
    AIDS Care; 2011 Feb; 23(2):245-51. PubMed ID: 21259138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.